{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:47Z","timestamp":1787003687834,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-154287"],"award-info":[{"award-number":["FDN-154287"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["COVID-19 Rapid Research Funding"],"award-info":[{"award-number":["COVID-19 Rapid Research Funding"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CGS-D"],"award-info":[{"award-number":["CGS-D"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["COVID-19 Rapid Research Funding"],"award-info":[{"award-number":["COVID-19 Rapid Research Funding"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32557-y","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:14:59Z","timestamp":1766142899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal gene expression analysis in COVID-19 sepsis highlights dynamic immune, cellular, and metabolic dysfunction in high severity patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Andy Y.","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Baghela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis M.","family":"Blimkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Acton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H. Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger C.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E. W.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"32557_CR1","unstructured":"Coronavirus Statistics. Worldometer https:\/\/www.worldometers.info\/coronavirus\/ (2025)."},{"key":"32557_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","volume":"399","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020\u201321. Lancet 399, 1513\u20131536 (2022).","journal-title":"Lancet"},{"key":"32557_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13054-021-03639-w","volume":"25","author":"C de Roquetaillade","year":"2021","unstructured":"de Roquetaillade, C. et al. Timing and causes of death in severe COVID-19 patients. Crit. Care. 25, 224 (2021).","journal-title":"Crit. Care"},{"key":"32557_CR4","doi-asserted-by":"publisher","first-page":"103776","DOI":"10.1016\/j.ebiom.2021.103776","volume":"75","author":"A Baghela","year":"2022","unstructured":"Baghela, A. et al. Predicting sepsis severity at first clinical presentation: the role of endotypes and mechanistic signatures. eBioMedicine 75, 103776 (2022).","journal-title":"eBioMedicine"},{"key":"32557_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-019-2372-2","volume":"23","author":"A Leligdowicz","year":"2019","unstructured":"Leligdowicz, A. & Matthay, M. A. Heterogeneity in sepsis: new biological evidence with clinical applications. Crit. Care. 23, 80 (2019).","journal-title":"Crit. Care"},{"key":"32557_CR6","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.4049\/jimmunol.2001325","volume":"206","author":"Q Yan","year":"2021","unstructured":"Yan, Q. et al. Longitudinal peripheral blood transcriptional analysis reveals molecular signatures of disease progression in COVID-19 patients. J. Immunol. 206, 2146\u20132159 (2021).","journal-title":"J. Immunol."},{"key":"32557_CR7","doi-asserted-by":"crossref","unstructured":"An, A. Y. et al. Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis. Front. Immunol. 14, 236 (2023).","DOI":"10.3389\/fimmu.2023.1254873"},{"key":"32557_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"32557_CR9","doi-asserted-by":"crossref","unstructured":"An, A. Y. et al. Severe COVID-19 and non-COVID-19 severe sepsis converge transcriptionally after a week in the intensive care unit, indicating common disease mechanisms. Front. Immunol. 14, 256 (2023).","DOI":"10.3389\/fimmu.2023.1167917"},{"key":"32557_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2217\/fmb-2020-0312","volume":"16","author":"JL Vincent","year":"2021","unstructured":"Vincent, J. L. COVID-19: it is all about sepsis. Future Microbiol. 16, 131\u2013133 (2021).","journal-title":"Future Microbiol."},{"key":"32557_CR11","first-page":"1","volume":"5","author":"HY Zheng","year":"2020","unstructured":"Zheng, H. Y. et al. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19. Signal. Transduct. Target. Ther. 5, 1\u201312 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"32557_CR12","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.immuni.2020.11.017","volume":"53","author":"JP Bernardes","year":"2020","unstructured":"Bernardes, J. P. et al. Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity 53, 1296\u20131314e9 (2020).","journal-title":"Immunity"},{"key":"32557_CR13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","volume":"183","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Multi-Omics resolves a Sharp Disease-State shift between mild and moderate COVID-19. Cell 183, 1479\u20131495e20 (2020).","journal-title":"Cell"},{"key":"32557_CR14","doi-asserted-by":"publisher","first-page":"e0245031","DOI":"10.1371\/journal.pone.0245031","volume":"16","author":"K Tremblay","year":"2021","unstructured":"Tremblay, K. et al. The Biobanque qu\u00e9b\u00e9coise de La COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories. PloS One. 16, e0245031 (2021).","journal-title":"PloS One"},{"key":"32557_CR15","unstructured":"Le, T. Updates on COVID-19 Variants of Concern (VOC). National Collaborating Centre for Infectious Diseases (2023). https:\/\/nccid.ca\/covid-19-variants\/."},{"key":"32557_CR16","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"JL Vincent","year":"1998","unstructured":"Vincent, J. L. et al. Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Crit. Care Med. 26, 1793\u20131800 (1998).","journal-title":"Crit. Care Med."},{"key":"32557_CR17","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"JC Marshall","year":"2020","unstructured":"Marshall, J. C. et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20, e192\u2013e197 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"32557_CR18","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2022)."},{"key":"32557_CR19","unstructured":"Babraham Bioinformatics. FastQC: a quality control tool for high throughput sequence data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"key":"32557_CR20","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & K\u00e4ller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"32557_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"32557_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2014a python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"32557_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"32557_CR24","unstructured":"Blighe, K. & Lun, A. PCAtools: everything principal component analysis. Bioconductor. https:\/\/www.bioconductor.org\/packages\/release\/bioc\/html\/PCAtools.html"},{"key":"32557_CR25","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.7717\/peerj.229","volume":"1","author":"ABK Foroushani","year":"2013","unstructured":"Foroushani, A. B. K., Brinkman, F. S. L. & Lynn, D. J. Pathway-GPS and SIGORA: identifying relevant pathways based on the over-representation of their gene-pair signatures. PeerJ 1, e229 (2013).","journal-title":"PeerJ"},{"key":"32557_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","volume":"18","author":"A Fabregat","year":"2017","unstructured":"Fabregat, A. et al. Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinform. 18, 142 (2017).","journal-title":"BMC Bioinform."},{"key":"32557_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425 (2015).","journal-title":"Cell. Syst."},{"key":"32557_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J. Integr. Biol. 16, 284\u2013287 (2012).","journal-title":"OMICS J. Integr. Biol."},{"key":"32557_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"32557_CR30","doi-asserted-by":"publisher","first-page":"e1012422","DOI":"10.1371\/journal.pcbi.1012422","volume":"20","author":"TM Blimkie","year":"2024","unstructured":"Blimkie, T. M., An, A. & Hancock, R. E. W. Facilitating pathway and network based analysis of RNA-Seq data with PathlinkR. PLOS Comput. Biol. 20, e1012422 (2024).","journal-title":"PLOS Comput. Biol."},{"key":"32557_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"JH Friedman","year":"2010","unstructured":"Friedman, J. H., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"32557_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1172\/JCI17745","volume":"111","author":"M Colonna","year":"2003","unstructured":"Colonna, M. DAP12 signaling: from immune cells to bone modeling and brain myelination. J. Clin. Invest. 111, 313\u2013314 (2003).","journal-title":"J. Clin. Invest."},{"key":"32557_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1042\/bj3480241","volume":"348","author":"AL Bishop","year":"2000","unstructured":"Bishop, A. L. & Hall, A. Rho GTPases and their effector proteins. Biochem. J. 348, 241\u2013255 (2000).","journal-title":"Biochem. J."},{"key":"32557_CR34","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo, M. et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics 31, 3069\u20133071 (2015).","journal-title":"Bioinformatics"},{"key":"32557_CR35","unstructured":"Ciusss de L\u2019Est de l\u2019\u00cele de Montr\u00e9al. Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19: A Single-Center, Observational Retrospective-Prospective Comparative Study. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04876573."},{"key":"32557_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1182\/bloodadvances.2020003513","volume":"5","author":"Y Zaid","year":"2021","unstructured":"Zaid, Y. et al. Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19. Blood Adv. 5, 635\u2013639 (2021).","journal-title":"Blood Adv."},{"key":"32557_CR37","doi-asserted-by":"publisher","first-page":"2050313X2110320","DOI":"10.1177\/2050313X211032089","volume":"9","author":"P Keith","year":"2021","unstructured":"Keith, P. et al. Unprovoked serotonin syndrome-like presentation of SARS-CoV-2 infection: a small case series. SAGE Open. Med. Case Rep. 9, 2050313X211032089 (2021).","journal-title":"SAGE Open. Med. Case Rep."},{"key":"32557_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/01.CIR.73.4.847","volume":"73","author":"GJ Johnson","year":"1986","unstructured":"Johnson, G. J., Leis, L. A. & Francis, G. S. Disparate effects of the calcium-channel blockers, Nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets. Circulation 73, 847\u2013854 (1986).","journal-title":"Circulation"},{"key":"32557_CR39","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3109\/08820139.2011.615877","volume":"40","author":"M Simitsopoulou","year":"2011","unstructured":"Simitsopoulou, M., Roilides, E. & Walsh, T. J. Immunomodulatory properties of antifungal agents on phagocytic cells. Immunol. Invest. 40, 809\u2013824 (2011).","journal-title":"Immunol. Invest."},{"key":"32557_CR40","doi-asserted-by":"crossref","unstructured":"Bailey, C. J. & Gwilt, M. Diabetes, Metformin and the clinical course of COVID-19: outcomes, mechanisms and suggestions on the therapeutic use of Metformin. Front. Pharmacol. 13, 152 (2022).","DOI":"10.3389\/fphar.2022.784459"},{"key":"32557_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"The RECOVERY Collaborative Group","year":"2021","unstructured":"The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med."},{"key":"32557_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03995-1","volume":"599","author":"S Lee","year":"2021","unstructured":"Lee, S. et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 599, 283\u2013289 (2021).","journal-title":"Nature"},{"key":"32557_CR43","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/s41598-023-28259-y","volume":"13","author":"A Baghela","year":"2023","unstructured":"Baghela, A. et al. Predicting severity in COVID-19 disease using sepsis blood gene expression signatures. Sci. Rep. 13, 1247 (2023).","journal-title":"Sci. Rep."},{"key":"32557_CR44","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1056\/NEJMoa2108163","volume":"385","author":"DM Weinreich","year":"2021","unstructured":"Weinreich, D. M. et al. REGEN-COV antibody combination and outcomes in outpatients with COVID-19. N. Engl. J. Med. 385, e81 (2021).","journal-title":"N. Engl. J. Med."},{"key":"32557_CR45","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa2033130","volume":"384","author":"ACTIV-3\/TICO LY-CoV555 Study Group","year":"2021","unstructured":"ACTIV-3\/TICO LY-CoV555 Study Group. A neutralizing monoclonal antibody for hospitalized patients with COVID-19. N. Engl. J. Med. 384, 905\u2013914 (2021).","journal-title":"N. Engl. J. Med."},{"key":"32557_CR46","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of COVID-19 \u2014 final report. N. Engl. J. Med. 383, 1813\u20131826 (2020).","journal-title":"N. Engl. J. Med."},{"key":"32557_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb, R. L. et al. Early Remdesivir to prevent progression to severe COVID-19 in outpatients. N. Engl. J. Med. 386, 305\u2013315 (2022).","journal-title":"N. Engl. J. Med."},{"key":"32557_CR48","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.bcp.2010.07.014","volume":"80","author":"A Paine","year":"2010","unstructured":"Paine, A., Eiz-Vesper, B., Blasczyk, R. & Immenschuh, S. Signaling to Heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol. 80, 1895\u20131903 (2010).","journal-title":"Biochem. Pharmacol."},{"key":"32557_CR49","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/jth.14848","volume":"18","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J. Thromb. Haemost. 18, 1469\u20131472 (2020).","journal-title":"J. Thromb. Haemost"},{"key":"32557_CR50","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.3390\/ijms25115941","volume":"25","author":"X Qiu","year":"2024","unstructured":"Qiu, X., Nair, M. G., Jaroszewski, L. & Godzik, A. Deciphering abnormal platelet subpopulations in COVID-19, sepsis and systemic lupus erythematosus through machine learning and Single-Cell transcriptomics. Int. J. Mol. Sci. 25, 5941 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"32557_CR51","doi-asserted-by":"crossref","unstructured":"An, A. Y. et al. Post-COVID symptoms are associated with endotypes reflecting poor inflammatory and hemostatic modulation. Front. Immunol. 14, 253 (2023).","DOI":"10.3389\/fimmu.2023.1243689"},{"key":"32557_CR52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/BCJ20220016","volume":"479","author":"DB Kell","year":"2022","unstructured":"Kell, D. B., Laubscher, G. J. & Pretorius, E. A central role for amyloid fibrin microclots in long COVID\/PASC: origins and therapeutic implications. Biochem. J. 479, 537\u2013559 (2022).","journal-title":"Biochem. J."},{"key":"32557_CR53","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S2213-2600(22)00021-2","volume":"10","author":"A Supady","year":"2022","unstructured":"Supady, A. & Zeiser, R. Baricitinib for patients with severe COVID-19\u2014time to change the standard of care? Lancet Respir. Med. 10, 314\u2013315 (2022).","journal-title":"Lancet Respir. Med."},{"key":"32557_CR54","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3389\/fonc.2020.01428","volume":"10","author":"S Galimberti","year":"2020","unstructured":"Galimberti, S. et al. Tyrosine kinase inhibitors play an antiviral action in patients affected by chronic myeloid leukemia: a possible model supporting their use in the fight against SARS-CoV-2. Front. Oncol. 10, 1428 (2020).","journal-title":"Front. Oncol."},{"key":"32557_CR55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1099\/jgv.0.001047","volume":"99","author":"JM Sisk","year":"2018","unstructured":"Sisk, J. M., Frieman, M. B. & Machamer, C. E. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. J. Gen. Virol. 99, 619\u2013630 (2018).","journal-title":"J. Gen. Virol."},{"key":"32557_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11095-020-02851-7","volume":"37","author":"E Weisberg","year":"2020","unstructured":"Weisberg, E. et al. Repurposing of kinase inhibitors for treatment of COVID-19. Pharm. Res. 37, 167 (2020).","journal-title":"Pharm. Res."},{"key":"32557_CR57","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3389\/fimmu.2018.00901","volume":"9","author":"CF Gon\u00e7alves-de-Albuquerque","year":"2018","unstructured":"Gon\u00e7alves-de-Albuquerque, C. F. et al. The Yin and Yang of tyrosine kinase Inhibition during experimental polymicrobial sepsis. Front. Immunol. 9, 901 (2018).","journal-title":"Front. Immunol."},{"key":"32557_CR58","doi-asserted-by":"crossref","unstructured":"Kan, C. et al. Mortality risk of antidiabetic agents for type 2 diabetes with COVID-19: a systematic review and meta-analysis. Front. Endocrinol. 12, 152 (2021).","DOI":"10.3389\/fendo.2021.708494"},{"key":"32557_CR59","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13098-015-0068-6","volume":"7","author":"BT Gao","year":"2015","unstructured":"Gao, B. T., Lee, R. P., Jiang, Y., Steinle, J. J. & Morales-Tirado, V. M. Pioglitazone alters monocyte populations and stimulates recent thymic emigrants in the BBDZR\/Wor type 2 diabetes rat model. Diabetol. Metab. Syndr. 7, 72 (2015).","journal-title":"Diabetol. Metab. Syndr."},{"key":"32557_CR60","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3389\/fimmu.2020.02056","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Immunomodulatory and antiviral activity of Metformin and its potential implications in treating coronavirus disease 2019 and lung injury. Front. Immunol. 11, 2056 (2020).","journal-title":"Front. Immunol."},{"key":"32557_CR61","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s13300-019-0651-1","volume":"10","author":"S Kalra","year":"2019","unstructured":"Kalra, S. et al. Glucocrinology of modern sulfonylureas: clinical evidence and practice-based opinion from an international expert group. Diabetes Ther. 10, 1577\u20131593 (2019).","journal-title":"Diabetes Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32557-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:11:00Z","timestamp":1769213460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32557-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32557"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32557-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RH has filed for patent protection all-cause sepsis endotype signatures, utilized here for analysis, and licenced these to Sepset Biosciences Inc., a subsidiary of Asep Medical Holdings Inc., in which he has a significant ownership position and serves as CEO and Board Chair. PZ is employed by Sepset Biosciences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2507"}}